Cargando…

Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms

BACKGROUND: Recent evidence from in vitro and in vivo studies has demonstrated that aberrant reactivation of the Sonic Hedgehog (SHH) signaling pathway regulates genes that promote cellular proliferation in various human cancer stem cells (CSCs). Therefore, the chemotherapeutic agents that inhibit a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Brahma N., Fu, Junsheng, Srivastava, Rakesh K., Shankar, Sharmila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210776/ https://www.ncbi.nlm.nih.gov/pubmed/22087285 http://dx.doi.org/10.1371/journal.pone.0027306

Ejemplares similares

Effect of the sonic hedgehog inhibitor GDC-0449 on an in vitro isogenic cellular model simulating odontogenic keratocysts
por: Zhai, Jiemei, et al.
Publicado: (2019)

GDC-0449 improves the antitumor activity of nano-doxorubicin in pancreatic cancer in a fibroblast-enriched microenvironment
por: Zhou, Quan, et al.
Publicado: (2017)

In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors
por: Benvenuto, Monica, et al.
Publicado: (2016)

Sonic Hedgehog Signaling Inhibition Provides Opportunities for Targeted Therapy by Sulforaphane in Regulating Pancreatic Cancer Stem Cell Self-Renewal
por: Rodova, Mariana, et al.
Publicado: (2012)

Inhibition of pancreatic cancer stem cell characteristics by α‐Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog
por: Ma, Yiming, et al.
Publicado: (2019)

The dawn of hedgehog inhibitors: Vismodegib
por: Sandhiya, Selvarajan, et al.
Publicado: (2013)

Vismodegib, an antagonist of hedgehog signaling, directly alters taste molecular signaling in taste buds
por: Yang, Hyekyung, et al.
Publicado: (2015)

PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth
por: Sharma, Narinder, et al.
Publicado: (2015)

EGCG Enhances the Therapeutic Potential of Gemcitabine and CP690550 by Inhibiting STAT3 Signaling Pathway in Human Pancreatic Cancer
por: Tang, Su-Ni, et al.
Publicado: (2012)

Resveratrol Inhibits Growth of Orthotopic Pancreatic Tumors through Activation of FOXO Transcription Factors
por: Roy, Sanjit K., et al.
Publicado: (2011)

Semi‐Mechanism‐Based Population Pharmacokinetic Modeling of the Hedgehog Pathway Inhibitor Vismodegib
por: Lu, T, et al.
Publicado: (2015)

Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma
por: De Jesus-Acosta, Ana, et al.
Publicado: (2019)

GDC respond to crisis
Publicado: (2020)

Mentoring, performance and the GDC
por: Saw, Mabel, et al.
Publicado: (2021)

Vismodegib: First-in-Class Hedgehog Pathway Inhibitor for Metastatic or Locally Advanced Basal Cell Carcinoma
por: Nix, Nancy M., et al.
Publicado: (2014)

Inhibition of CAL27 Oral Squamous Carcinoma Cell by Targeting Hedgehog Pathway With Vismodegib or Itraconazole
por: Freitas, Raíza Dias, et al.
Publicado: (2020)

Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
por: Catenacci, Daniel V.T., et al.
Publicado: (2015)

Activation of AMPK sensitizes medulloblastoma to Vismodegib and overcomes Vismodegib‐resistance
por: Gampala, Silpa, et al.
Publicado: (2021)

Embelin Suppresses Growth of Human Pancreatic Cancer Xenografts, and Pancreatic Cancer Cells Isolated from Kras(G12D) Mice by Inhibiting Akt and Sonic Hedgehog Pathways
por: Huang, Minzhao, et al.
Publicado: (2014)

Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib
por: Hehlgans, Stephanie, et al.
Publicado: (2018)

GDC announces new chair
Publicado: (2021)

Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
por: Nalls, Dara, et al.
Publicado: (2011)

Deciphering the Allosteric Effect of Antagonist Vismodegib on Smoothened Receptor Deactivation Using Metadynamics Simulation
por: An, Xiaoli, et al.
Publicado: (2019)

Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression
por: Petrirena, Gregorio J., et al.
Publicado: (2018)

Vismodegib hedgehog-signaling inhibition and treatment of basal cell carcinomas as well as keratocystic odontogenic tumors in Gorlin syndrome
por: Booms, Patrick, et al.
Publicado: (2015)

Chronic ethanol exposure of human pancreatic normal ductal epithelial cells induces cancer stem cell phenotype through SATB2
por: Yu, Wei, et al.
Publicado: (2018)

Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms
por: Kumar, Dhruv, et al.
Publicado: (2013)

Pilomatricomas secondary to treatment with vismodegib
por: Magdaleno-Tapial, Jorge, et al.
Publicado: (2018)

Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and Kras(G12D) Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition
por: Shankar, Sharmila, et al.
Publicado: (2011)

0449. Surface EMG of extra-diaphragmatic muscles can assess muscle unloading during neurally adjusted ventilatory support
por: Somhorst, P, et al.
Publicado: (2014)

The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition
por: Tang, Su-Ni, et al.
Publicado: (2010)

GDC 2: Compression of large collections of genomes
por: Deorowicz, Sebastian, et al.
Publicado: (2015)

GDC publishes 2019 fitness to practise statistics
Publicado: (2020)

GDC statement on complaints during the pandemic welcomed
Publicado: (2022)

GDC calls for DCPs to check CPD records
Publicado: (2022)

GDC calls for DCPs to check CPD records
Publicado: (2022)

A case of hepatotoxicity associated with vismodegib
por: Ly, Priscilla, et al.
Publicado: (2018)

Rare bone toxicity associated with vismodegib
por: Ciciarelli, Valeria, et al.
Publicado: (2020)

The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives
por: Quoc Lam, Bao, et al.
Publicado: (2020)

Hedgehog-Interacting Protein is a multimodal antagonist of Hedgehog signalling
por: Griffiths, Samuel C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_trhgmr7bb5bel5h9lvo0o1a7g9